HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sahar Roozbehi Selected Research

3- (4- (2- (3- chlorophenylamino)pyrimidin- 4- yl)pyridin- 2- ylamino)propanol

11/2021Drug repositioning based on gene expression data for human HER2-positive breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sahar Roozbehi Research Topics

Disease

3Neoplasms (Cancer)
11/2021 - 10/2020
1Breast Neoplasms (Breast Cancer)
11/2021

Drug/Important Bio-Agent (IBA)

2CurcuminIBA
11/2021 - 10/2020
13- (4- (2- (3- chlorophenylamino)pyrimidin- 4- yl)pyridin- 2- ylamino)propanolIBA
11/2021
1human ERBB2 proteinIBA
11/2021
1mocetinostatIBA
11/2021
14- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamideIBA
11/2021
1VorinostatFDA Link
11/2021
1alvocidib (flavopiridol)IBA
11/2021
1N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamideIBA
11/2021
1Pharmaceutical PreparationsIBA
11/2021
1Ethidium (Ethidium Bromide)IBA
03/2021
1Annexin A5IBA
03/2021
1Acridine OrangeIBA
03/2021
1Dextrans (Dextran)FDA Link
10/2020
1Trastuzumab (Herceptin)FDA Link
10/2020
1EnzymesIBA
10/2020

Therapy/Procedure

1Therapeutics
10/2020